PDF herunterladen
Pharmacopsychiatry 2004; 37(3): 110-118
DOI: 10.1055/s-2004-818988
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Kinematical Analysis of Motor Function in Schizophrenic Patients: a Possibility to Separate Negative Symptoms from Extrapyramidal Dysfunction Induced by Neuroleptics?

Verena Henkel1 , Roland Mergl1 , Martin Schäfer2 , Dan Rujescu1 , Hans-Jürgen Möller1 , Ulrich Hegerl1
  • 1Department of Psychiatry, Ludwig-Maximilians-University Munich, Munich, Germany
  • 2Department of Psychiatry, Charité, Berlin, Germany
Weitere Informationen

Publikationsverlauf

Received: 11.12.2002 Revised: 2.4.2003

Accepted: 30.04.2003

Publikationsdatum:
12. Mai 2004 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Background: In this prospective matched case-control study, hand movement analysis was conducted using a digitizing tablet (kinematical analysis). Methods: The study examined the association of different computer-assessed hand movement variables with clinical pathology (negative symptoms and extrapyramidal motor dysfunction). A sample of 16 schizophrenic patients and 16 healthy controls participated in the study. Results: At baseline, kinematical analysis indicated a significant higher prevalence of subtle hand motor dysfunction in unmedicated schizophrenic patients (who all exhibited clinically no extrapyramidal dysfunction) in comparison to healthy controls. No association between the observed motor signs and pre-enrollment total long-term butyrophenones exposure has been detected. After 14 days treatment with haloperidol, the hand movement variables, which correlated significantly with clinical rating scores reflecting drug-induced extrapyramidal dysfunction could definitely be separated from the hand movement variables with a close association to clinical rating measuring negative symptoms. Conclusions: Results of the comparative analysis at baseline confirm previous findings concerning presence of neurological soft signs in unmedicated schizophrenic patients. Furthermore, results of this pilot study suggest that kinematical analysis by means of a digitizing tablet could be a useful approach towards a differentiation between drug-induced akinetic symptoms and disease-induced negative symptoms.

References

  • 1 Alexander G E, DeLong M R, Strick P L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex.  Annu Rev Neurosci. 1986;  9 357-381
    CrossrefPubMedSuche in Google Scholar
  • 2 American Psychiatric A ssociation. Diagnostic and Statistical Manual of Mental Disorders (4th edition) (DSM-IV). Washington, DC; American Psychiatric Association 1987
    Suche in Google Scholar
  • 3 Browne S, Clarke M, Gervin M, Lane A, Waddington J L, Larkin C. et al . Determinants of neurological dysfunction in first episode schizophrenia.  Psychol Med. 2000;  30 1433-1441
    CrossrefPubMedSuche in Google Scholar
  • 4 Buchanan R W, Kirkpatrick B, Heinrichs D W, Carpenter WT J r. Clinical correlates of the deficit syndrome of schizophrenia.  Am J Psychiatry. 1990;  147 290-294
    PubMedSuche in Google Scholar
  • 5 Chen E Y, Kwok C L, Au J W, Chen R Y, Lau B S. Progressive deterioration of soft neurological signs in chronic schizophrenic patients.  Acta Psychiat Scand. 2000;  102 342-349
    PubMedSuche in Google Scholar
  • 6 Chouinard G, Ross-Chouinard A, Annable L, Jones B D. The Extrapyramidal Symptom Rating Scale.  Can J Neurol Sci. 1980;  7 233
    PubMedSuche in Google Scholar
  • 7 Cunnington R, Bradshaw J L, Iansek R. The role of the supplementary motor area in the control of voluntary movement.  Hum Mov Sci. 1996;  15 627-647
    CrossrefPubMedSuche in Google Scholar
  • 8 Eichhorn T, Gasser T, Mai N, Marquardt C, Arnold G, Schwarz J. et al . Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects.  Mov Disord. 1996;  11 289-297
    CrossrefPubMedSuche in Google Scholar
  • 9 Flyckt L, Borg J, Borg K, Ansved T, Edman G, Bjerkenstedt L. et al . Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia.  Biol Psychiatry. 2000;  47 991-999
    CrossrefPubMedSuche in Google Scholar
  • 10 Gallucci R M, Phillips J G, Bradshaw J L, Vaddadi K S, Pantelis C. Kinematic analysis of handwriting movements in schizophrenic patients.  Biol Psychiat. 1997;  41 830-833
    PubMedSuche in Google Scholar
  • 11 Haase H J. Über Vorkommen und Deutung des psychomotorischen Parkinsonsyndroms bei Megaphen- bzw. Largactil-Dauerbehandlung.  Nervenarzt. 1954;  25 486-492
    Suche in Google Scholar
  • 12 Haase H J, Kaumeier S, Schwarz S, Gundel A, Linde O K, von Bomhard R H. et al . Clinical trial of droperidol for the determination of the neuroleptic threshold and the neuroleptic-therapeutic range.  Int Pharmacopsychiatry. 1980;  15 74-80
    PubMedSuche in Google Scholar
  • 13 Heinz A, Knable M B, Coppola R, Gorey J G, Jones D W, Lee K S. et al . Psychomotor slowing, negative symptoms and dopamine receptor availability - an IBZM SPECT study in neuroleptic-treated and drug-free schizophrenic patients.  Schizophr Res. 1998;  31 19-26
    CrossrefPubMedSuche in Google Scholar
  • 14 Henkel V, Mergl R, Juckel G, Rujescu D, Mavrogiorgou P, Giegling I. et al . Assessment of handedness using a digitizing tablet: a new method.  Neuropsychologia. 2001;  39 1158-1166
    CrossrefPubMedSuche in Google Scholar
  • 15 Jahn T, Cohen R, Mai N, Ehrensperger M, Marquardt C, Nitsche N. et al . Untersuchung der fein- und grobmotorischen Dysdiadochokinese schizophrener Patienten: Methodenentwicklung und erste Ergebnisse einer computergestützten Mikroanalyse.  Zeitschr Klin Psychol. 1995;  24 300-315
    PubMedSuche in Google Scholar
  • 16 Jahn T, Mussgay L. Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophreniestudien. Ein Vorschlag zur Berechnung von Chlorpromazinäquivalenten.  Zeitschr Klin Psychol. 1989;  18 257-267
    PubMedSuche in Google Scholar
  • 17 Jogems-Kosterman B J, Zitman F G, van Hoof J J, Hulstijn W. Psychomotor slowing and planning deficits in schizophrenia.  Schizophr Res. 2001;  48 317-333
    CrossrefPubMedSuche in Google Scholar
  • 18 Kay S R, Fiszbein A, Opler L A. Positive and Negative Symptom Scale (PANSS) for schizophrenia.  Schizophr Bull. 1988;  13 21-76
    PubMedSuche in Google Scholar
  • 19 Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh; Livingstone 1919
    Suche in Google Scholar
  • 20 Marquardt C, Mai N. CS-Computerunterstützte Analyse der Bewegungsabläufe beim Schreiben. München; MedCom 1992
    Suche in Google Scholar
  • 21 Marquardt C, Mai N. A computational procedure for movement analysis in handwriting.  J Neurosci Methods. 1994;  52 39-45
    CrossrefPubMedSuche in Google Scholar
  • 22 Mergl R, Tigges P, Schröter A, Möller H -J, Hegerl U. Digitized analysis of handwriting and drawing movements in healthy subjects. Methods, results and perspectives.  J Neurosci Methods. 1999;  90 157-169
    CrossrefPubMedSuche in Google Scholar
  • 23 Mori K, Yamashita H, Nagao M, Horiguchi J, Yamawaki S. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.  Pharmacopsychiatry. 2002;  35 6-11
    Thieme ConnectPubMedSuche in Google Scholar
  • 24 Peralta V, Cuesta M J. Motor features in psychotic disorders. I: Factor structure and clinical correlates.  Schizophr Res. 2001;  47 107-116
    CrossrefPubMedSuche in Google Scholar
  • 25 Poyurovsky M, Nave R, Epstein R, Tzischinsky O, Schneidman M, Barnes T R. et al . Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia.  Eur Neuropsychopharmacol. 2000;  10 171-176
    PubMedSuche in Google Scholar
  • 26 Sabbe B, Hulstijn W, van Hoof J JM, Tuynman-Qua H G, Zitman F. Retardation in depression: assessment by means of simple motor tasks.  J Affect Disord. 1999;  55 39-44
    CrossrefPubMedSuche in Google Scholar
  • 27 Sabbe B, Hulstijn W, van Hoof J JM, Zitman F. Fine motor retardation and depression.  J Psychiatry Res. 1996;  30 295-306
    PubMedSuche in Google Scholar
  • 28 Schäfer M, Rujescu D, Giegling I, Guntermann A, Erfurth A, Bondy B. et al . Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene.  Am J Psychiatry. 2001;  158 802-804
    CrossrefPubMedSuche in Google Scholar
  • 29 Schmidt K, Nolte-Zenker B, Patzer J, Bauer M, Schmidt L G, Heinz A. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.  Pharmacopsychiatry. 2001;  34 66-72
    Thieme ConnectPubMedSuche in Google Scholar
  • 30 Schröder J, Essig M, Baudendistel K, Jahn T, Gerdsen I, Stockert A. et al . Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: A study with functional magnetic resonance imaging.  Neuroimage. 1999;  9 81-87
    CrossrefPubMedSuche in Google Scholar
  • 31 Schröder J, Wenz F, Schad L R, Baudendistel K, Knopp M V. Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging.  Br J Psychiatry. 1995;  167 197-201
    PubMedSuche in Google Scholar
  • 32 Shiffman S M, Gritz E R, Maltese J, Lee M A, Schneider N G, Jarvik M E. Effects of cigarette smoking and oral nicotine on hand tremor.  Clin Pharmacol Ther. 1983;  33 800-805
    PubMedSuche in Google Scholar
  • 33 Tigges P, Mergl R, Frodl T, Meisenzahl E M, Gallinat J, Schröter A. et al . Digitized analysis of abnormal hand-motor performance in schizophrenic patients.  Schizophr Res. 2000;  45 133-143
    CrossrefPubMedSuche in Google Scholar
  • 34 Weinberger D R. A connectionist approach to the prefrontal cortex.  J Neuropsychiatry Clin Neurosci. 1993;  5 241-253
    PubMedSuche in Google Scholar
  • 35 World Medical A ssociation. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.  JAMA. 1997;  277 925-926
    CrossrefPubMedSuche in Google Scholar

Verena  HenkelM.D. 

Department of Psychiatry

Ludwig-Maximilians-University Munich

Nußbaumstr. 7

80336 Munich

Germany

Telefon: +49/089-5160-5558

Fax: +49/089-5160-5542

eMail: Verena.Henkel@psy.med.uni-muenchen.de